Esparma GmbH is pleased to present you the first BlemaStone® mobile application designed specifically for patients taking Blemaren®. The application allows you to simply and conveniently select the dose of Blemaren®.
Blemaren® is a drug used in urolithiasis to dissolve stones in the urinary tract, as well as to prevent their re-formation.
The application allows the patient to receive: • assistance in the individual calculation of the dose of the drug - Blemaren®; • quick access from mobile devices to information about urolithiasis; • convenient pop-up Push-reminders about compliance with the drinking regime and measurement of urine pH; • recommendations on lifestyle and diet for different types of stones; • there is a "question-answer" section where you can find answers to your questions.
Mar 27, 2023
Safety starts with understanding how developers collect and share your data. Data privacy and security practices may vary based on your use, region, and age. The developer provided this information and may update it over time.
This app may share these data types with third parties